Atea Pharmaceuticals, Inc.AVIRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
3Y CAGR+13.7%
5Y CAGR+187.8%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+13.7%/yr
vs +128.0%/yr prior
5Y CAGR
+187.8%/yr
Recent deceleration
Acceleration
-114.3pp
Decelerating
Percentile
P71
Within normal range
vs 5Y Ago
197.3x
Strong expansion
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $16.38M | -35.8% |
| 2024 | $25.49M | -12.8% |
| 2023 | $29.22M | +162.1% |
| 2022 | $11.15M | +5135.2% |
| 2021 | $213000.00 | +156.6% |
| 2020 | $83000.00 | -85.5% |
| 2019 | $574000.00 | +39.0% |
| 2018 | $413000.00 | - |